Camostat Efficacy vs. Placebo for Outpatient Treatment of COVID-19 (CAMELOT)
Public ClinicalTrials.gov record NCT04583592. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Efficacy of Camostat Mesilate for Treatment of COVID-19 in Outpatients
Study identification
- NCT ID
- NCT04583592
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sagent Pharmaceuticals Inc.
- Industry
- Enrollment
- 295 participants
Conditions and interventions
Conditions
Interventions
- Camostat Mesilate Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 8, 2020
- Primary completion
- Mar 30, 2021
- Completion
- Mar 30, 2021
- Last update posted
- Jan 17, 2022
2020 – 2021
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palmtree Clinical Research, Inc. (Site 125) | Palm Springs | California | 92262 | — |
| Synergy Healthcare, LLC (Site 124) | Bradenton | Florida | 34208 | — |
| Clinical Research of Brandon, LLC (Site 123) | Brandon | Florida | 33511 | — |
| Reliable Clinical Research, LLC (Site 100) | Hialeah | Florida | 33012 | — |
| A+ Research (Site 112) | Miami | Florida | 33144 | — |
| NextPhase Research Alliance at CANO HEALTH (Site 107) | Miami | Florida | 33144 | — |
| Ezy Medical Research (Site 106) | Miami | Florida | 33175 | — |
| Eminat LLC (Site 117) | Plantation | Florida | 33317 | — |
| Invictus Clinical Research Group, LLC (Site 101) | Pompano Beach | Florida | 33064 | — |
| Visionaries Clinical Research, LLC (Site 121) | Atlanta | Georgia | 30318 | — |
| Family Care Research (Site 114) | Boise | Idaho | 83704 | — |
| Cedar Crosse Research Center (Site 122) | Chicago | Illinois | 60607 | — |
| Massachusetts General Hospital (Site 110) | Boston | Massachusetts | 02114 | — |
| Oakland Medical Research Center (Site 108) | Troy | Michigan | 48085 | — |
| Cary Research Group (Site 111) | Cary | North Carolina | 27518 | — |
| Onsite Solutions (Site 118) | Charlotte | North Carolina | 28208 | — |
| STAT Research (Site 109) | Springboro | Ohio | 45066 | — |
| Toledo Institute of Clinical Research, Inc.(Site 105) | Toledo | Ohio | 43617 | — |
| Advanced Medical Trials (Site 104) | Georgetown | Texas | 78628 | — |
| Next Innovative Clinical Research (Site 115) | Houston | Texas | 77021 | — |
| Rio Grand Valley Clinical Research Institute (Site 120) | Pharr | Texas | 78577 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04583592, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2022 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04583592 live on ClinicalTrials.gov.